WVE logo

Wave Life Sciences Ltd. (WVE) Cash from operations

annual CFO:

-$151.03M-$131.59M(-677.24%)
December 31, 2024

Summary

  • As of today (September 16, 2025), WVE annual cash flow from operations is -$151.03 million, with the most recent change of -$131.59 million (-677.24%) on December 31, 2024.
  • During the last 3 years, WVE annual CFO has fallen by -$62.03 million (-69.71%).
  • WVE annual CFO is now -4153.06% below its all-time high of -$3.55 million, reached on December 31, 2013.

Performance

WVE Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

quarterly CFO:

-$48.00M+$15.04M(+23.86%)
June 30, 2025

Summary

  • As of today (September 16, 2025), WVE quarterly cash flow from operations is -$48.00 million, with the most recent change of +$15.04 million (+23.86%) on June 30, 2025.
  • Over the past year, WVE quarterly CFO has dropped by -$20.82 million (-76.58%).
  • WVE quarterly CFO is now -156.13% below its all-time high of $85.52 million, reached on March 31, 2023.

Performance

WVE quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

TTM CFO:

-$201.93M-$20.82M(-11.49%)
June 30, 2025

Summary

  • As of today (September 16, 2025), WVE TTM cash flow from operations is -$201.93 million, with the most recent change of -$20.82 million (-11.49%) on June 30, 2025.
  • Over the past year, WVE TTM CFO has dropped by -$73.85 million (-57.66%).
  • WVE TTM CFO is now -12380.12% below its all-time high of -$1.62 million, reached on March 31, 2023.

Performance

WVE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

WVE Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-677.2%-76.6%-57.7%
3 y3 years-69.7%-70.3%-97.2%
5 y5 years+19.8%-27.8%-19.4%

WVE Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-677.2%at low-156.1%+23.9%<-9999.0%at low
5 y5-year-677.2%+19.8%-156.1%+23.9%<-9999.0%at low
alltimeall time-4153.1%+19.8%-156.1%+23.9%<-9999.0%at low

WVE Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$48.00M(-23.9%)
-$201.93M(+11.5%)
Mar 2025
-
-$63.04M(+47.6%)
-$181.11M(+19.5%)
Dec 2024
-$151.03M(+677.2%)
-$42.71M(-11.4%)
-$151.50M(+6.8%)
Sep 2024
-
-$48.18M(+77.3%)
-$141.85M(+10.8%)
Jun 2024
-
-$27.18M(-18.7%)
-$128.08M(-7.4%)
Mar 2024
-
-$33.43M(+1.1%)
-$138.28M(+615.4%)
Dec 2023
-$19.43M(-84.8%)
-$33.06M(-3.9%)
-$19.33M(-5.7%)
Sep 2023
-
-$34.41M(-8.0%)
-$20.49M(+89.3%)
Jun 2023
-
-$37.39M(-143.7%)
-$10.82M(+568.9%)
Mar 2023
-
$85.52M(-349.9%)
-$1.62M(-98.7%)
Dec 2022
-$127.78M(+43.6%)
-$34.22M(+38.3%)
-$127.01M(+27.3%)
Sep 2022
-
-$24.74M(-12.2%)
-$99.80M(-2.5%)
Jun 2022
-
-$28.18M(-29.3%)
-$102.39M(+22.5%)
Mar 2022
-
-$39.87M(+469.1%)
-$83.62M(-5.1%)
Dec 2021
-$88.99M(-23.3%)
-$7.01M(-74.4%)
-$88.12M(-23.1%)
Sep 2021
-
-$27.34M(+190.6%)
-$114.59M(+5.3%)
Jun 2021
-
-$9.41M(-78.8%)
-$108.79M(-20.6%)
Mar 2021
-
-$44.38M(+32.6%)
-$136.95M(+15.3%)
Dec 2020
-$115.98M(-38.4%)
-$33.47M(+55.4%)
-$118.82M(-19.5%)
Sep 2020
-
-$21.54M(-42.7%)
-$147.63M(-12.7%)
Jun 2020
-
-$37.57M(+43.1%)
-$169.13M(+3.0%)
Mar 2020
-
-$26.25M(-57.9%)
-$164.23M(-12.8%)
DateAnnualQuarterlyTTM
Dec 2019
-$188.23M(+723.3%)
-$62.28M(+44.7%)
-$188.36M(+19.0%)
Sep 2019
-
-$43.03M(+31.7%)
-$158.28M(+9.7%)
Jun 2019
-
-$32.67M(-35.2%)
-$144.22M(+257.1%)
Mar 2019
-
-$50.38M(+56.5%)
-$40.39M(+80.0%)
Dec 2018
-$22.86M(-72.7%)
-$32.20M(+11.1%)
-$22.43M(+70.8%)
Sep 2018
-
-$28.97M(-140.7%)
-$13.13M(+50.4%)
Jun 2018
-
$71.16M(-319.5%)
-$8.73M(-91.3%)
Mar 2018
-
-$32.43M(+41.6%)
-$100.30M(+17.6%)
Dec 2017
-$83.67M(+162.1%)
-$22.90M(-6.8%)
-$85.30M(+14.2%)
Sep 2017
-
-$24.57M(+20.4%)
-$74.71M(+20.2%)
Jun 2017
-
-$20.41M(+17.2%)
-$62.16M(+49.9%)
Mar 2017
-
-$17.42M(+41.5%)
-$41.47M(+33.0%)
Dec 2016
-$31.93M(+154.8%)
-$12.31M(+2.4%)
-$31.19M(+22.8%)
Sep 2016
-
-$12.02M(-4390.0%)
-$25.39M(+56.6%)
Jun 2016
-
$280.30K(-103.9%)
-$16.22M(-9.3%)
Mar 2016
-
-$7.14M(+9.6%)
-$17.89M(+44.6%)
Dec 2015
-$12.53M(+183.0%)
-$6.51M(+128.7%)
-$12.37M(+111.2%)
Sep 2015
-
-$2.85M(+104.6%)
-$5.86M(+94.6%)
Jun 2015
-
-$1.39M(-14.0%)
-$3.01M(+86.0%)
Mar 2015
-
-$1.62M
-$1.62M
Dec 2014
-$4.43M(+24.6%)
-
-
Dec 2013
-$3.55M
-
-

FAQ

  • What is Wave Life Sciences Ltd. annual cash flow from operations?
  • What is the all time high annual CFO for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. annual CFO year-on-year change?
  • What is Wave Life Sciences Ltd. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. quarterly CFO year-on-year change?
  • What is Wave Life Sciences Ltd. TTM cash flow from operations?
  • What is the all time high TTM CFO for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. TTM CFO year-on-year change?

What is Wave Life Sciences Ltd. annual cash flow from operations?

The current annual CFO of WVE is -$151.03M

What is the all time high annual CFO for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high annual cash flow from operations is -$3.55M

What is Wave Life Sciences Ltd. annual CFO year-on-year change?

Over the past year, WVE annual cash flow from operations has changed by -$131.59M (-677.24%)

What is Wave Life Sciences Ltd. quarterly cash flow from operations?

The current quarterly CFO of WVE is -$48.00M

What is the all time high quarterly CFO for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high quarterly cash flow from operations is $85.52M

What is Wave Life Sciences Ltd. quarterly CFO year-on-year change?

Over the past year, WVE quarterly cash flow from operations has changed by -$20.82M (-76.58%)

What is Wave Life Sciences Ltd. TTM cash flow from operations?

The current TTM CFO of WVE is -$201.93M

What is the all time high TTM CFO for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high TTM cash flow from operations is -$1.62M

What is Wave Life Sciences Ltd. TTM CFO year-on-year change?

Over the past year, WVE TTM cash flow from operations has changed by -$73.85M (-57.66%)
On this page